Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares trading hands.
Anthera Pharmaceuticals Price Performance
About Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Recommended Stories
- Five stocks we like better than Anthera Pharmaceuticals
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- How to Invest in Blue Chip Stocks
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Industrial Products Stocks Investing
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
